Thyroid Peroxidase Autoantibody Prevalence and Its Association with IA-2 Autoantibodies in Patients with Type 1 Diabetes Mellitus in Al-Najaf Province, Iraq.
Medical Science Journal for Advance Research · 01.09.2026 · 7 (3)
DOI: 10.46966/msjar.v7i3.454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 01.09.2026. Verfasst von Muhamed Ali Al Kabe. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that may coexist with other organ-specific autoimmune conditions, particularly thyroid autoimmunity. Thyroid peroxidase antibodies (TPO-Abs) are important serological markers used to assess thyroid autoimmunity in patients with T1DM.
Objective
This study aimed to determine the prevalence of TPO-Abs positivity and evaluate its association with IA-2A positivity and serum IA-2A levels among patients with T1DM in Al-Najaf Province, Iraq.
Methods
A hospital-based analytical cross-sectional study was conducted at the Diabetes Center of Al-Sadr Medical City, Al-Najaf, Iraq, between September 2022 and May 2023. The study included 30 patients with T1DM and 20 apparently healthy controls. Serum TPO-Abs and IA-2 autoantibodies (IA-2A) were measured using enzyme-linked immunosorbent assays kits.
Results
Patients with T1DM had significantly higher mean serum TPO-Ab levels than controls (77.56 ± 30.26 vs. 7.03 ± 0.84 IU/mL, P = 0.027). Similarly, IA-2A levels were higher in patients with T1DM than in controls (255.51 ± 118.43 vs. 4.92 ± 0.38 U/mL, P = 0.043). TPO-Ab positivity was detected in 9 of 30 patients with T1DM (30.0%) and was significantly associated with IA-2A positivity (P < 0.001). Among patients with T1DM, TPO-Abs and IA-2A levels showed a strong positive correlation (r = 0.895, P < 0.001).
Conclusion
TPO-Abs positivity was detected in 30.0% of patients with T1DM and was significantly associated with IA-2A positivity. These findings suggest coexistence of thyroid and islet autoimmunity among patients with T1DM; however, large studies are needed to confirm this association.
Zitieren
APA
Kabe, M. A. A. (2026). Thyroid Peroxidase Autoantibody Prevalence and Its Association with IA-2 Autoantibodies in Patients with Type 1 Diabetes Mellitus in Al-Najaf Province, Iraq. Medical Science Journal for Advance Research, 7(3). https://doi.org/10.46966/msjar.v7i3.454
Vancouver
Kabe MAA. Thyroid Peroxidase Autoantibody Prevalence and Its Association with IA-2 Autoantibodies in Patients with Type 1 Diabetes Mellitus in Al-Najaf Province, Iraq. Medical Science Journal for Advance Research. 2026;7(3). doi:10.46966/msjar.v7i3.454
BibTeX
@article{Kabe2026,
author = {Kabe, Muhamed Ali Al},
title = {Thyroid Peroxidase Autoantibody Prevalence and Its Association with IA-2 Autoantibodies in Patients with Type 1 Diabetes Mellitus in Al-Najaf Province, Iraq},
journal = {Medical Science Journal for Advance Research},
year = {2026},
volume = {7},
number = {3},
doi = {10.46966/msjar.v7i3.454}
}
EUVIMED